Search Result
List
2015-09-30 - 2019-07-01
Phase II
-
Condition/Disease
Stage IV Squamous Non-Small Cell Lung Cancer
-
Test Drug
Abemaciclib (LY2835219)
Participate Sites
5Sites
Terminated4Sites
2018-05-01 - 2021-06-30
Phase II
-
Condition/Disease
Active Proliferative Lupus Nephritis
-
Test Drug
CFZ533
Participate Sites
4Sites
Recruiting3Sites
2015-09-15 - 2019-09-30
Phase III
-
Condition/Disease
Esophageal cancer
-
Test Drug
ONO-4538 (Nivolumab)
Participate Sites
13Sites
Terminated11Sites
Division of Hematology & Oncology
2018-10-01 - 2021-03-31
Phase I
-
Condition/Disease
Solid tumors
-
Test Drug
nal-IRI
Participate Sites
5Sites
Recruiting3Sites
Terminated1Sites
2015-10-15 - 2020-06-30
Phase II
-
Condition/Disease
Active Systemic Lupus Erythematosus
-
Test Drug
STELARA
Participate Sites
6Sites
Terminated4Sites
Study ended1Sites
2015-10-22 - 2019-12-31
Phase III
-
Condition/Disease
Squamous Cell Head and Neck Cancer
-
Test Drug
MEDI4736; Tremelimumab
Participate Sites
8Sites
Terminated7Sites
Division of Otolaryngology
2017-02-07 - 2017-09-05
Phase III
-
Condition/Disease
Influenza
-
Test Drug
AdimFlu-S (QIS) Influenza Vaccine
Participate Sites
2Sites
Terminated1Sites
2017-06-28 - 2020-12-31
Phase I
-
Condition/Disease
Advanced Refractory Solid Tumors
-
Test Drug
T-1101 (Tosylate)
Participate Sites
5Sites
Suspended4Sites
Division of Hematology & Oncology
2017-10-01 - 2021-03-31
Phase II
-
Condition/Disease
Type 2 Diabetes Mellitus
-
Test Drug
CS02 Tablet
Participate Sites
13Sites
Recruiting2Sites
Terminated10Sites
Division of Endocrinology
2015-10-26 - 2017-05-30
Phase III
-
Condition/Disease
Chronic Hepatitis C Virus Genotype 1 Infection
-
Test Drug
ABT-493/ABT-530
Participate Sites
9Sites
Terminated8Sites
Digestive System Department